Amedisys has been among the many home health and hospice providers taking financial and operational hits as the coronavirus pandemic continues its spread, Hospice News reports. Despite facing headwinds, the company remains steadfast in its position on hospice as it seeks to further build up its presence in the market. Read more.
Related Posts
Demand for Primary Care Projected to Slow as Amazon, Walmart Pose a Growing Threat: Report
Patients have more choices than before with the increasing supply of new entrants like CVS, Amazon and Walmart making consumer loyalty more difficult to capture.
October 20, 2022
Biggest Health Deals of 2022
Healthcare disruptors had a busy 2022 as major firms, such as Amazon, entered the healthcare space through mergers and acquisitions.
December 29, 2022
How Health Systems & Private Equity-Backed Platforms Can Fuel Mutual Growth
In the U.S., where healthcare represents about 20 percent of the economy, a proportional amount of PE is allocated to healthcare investments, representing about $500 billion.
October 17, 2023
Behavioral Health Transactions Down After ‘Outlier Year,’ But Ample Dealmaking Action Still Expected
Overall, the behavioral health sector saw 53 deals in the first half of 2022.
August 19, 2022